USE OF TUMOR NECROSIS FACTOR-A INHIBITORS IN RHEUMATOID ARTHRITIS: TOPICAL ASPECTS
The use of tumor necrosis factor (TNF) а inhibitors in combination with methotrexate remains the basic method for treating active rheumatoid arthritis (RA). This line in antirheumatic therapy is rapidly developing. A number of unsolved issues associated with the selection of patients (particularly a...
Saved in:
| Main Authors: | E L Luchikhina, D E Karateev, Ye L Luchikhina, D E Karateyev |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2008-12-01
|
| Series: | Современная ревматология |
| Online Access: | https://mrj.ima-press.net/mrj/article/view/192 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nimesulide in rheumatoid arthritis
by: E. L. Luchikhina
Published: (2015-06-01) -
New ACR/EULAR 2010 classification criteria for rheumatoid arthritis: a step forward in its early diagnosis
by: Dmitriy Evgen'evich Karateev, et al.
Published: (2011-02-01) -
Tumor necrosis factor-α inhibitors and their effects on cardiovascular risk factorsin patients with rheumatoid arthritis
by: O G Lineva, et al.
Published: (2010-02-01) -
Ihmor necrosis factor-a inhibitors and cardiovascular risk in rheumatoid arthritis
by: Tatiana Valentinovna Popkova, et al.
Published: (2012-12-01) -
Treatment strategy for rheumatoid arthritis: hot topics
by: D. E. Karateev
Published: (2015-03-01)